Skip to main
NNOX
NNOX logo

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging Ltd has demonstrated solid financial performance with a quarterly revenue increase to $3.4 million, attributed to enhanced teleradiology utilization and improved operational margins. The company's strategic initiatives, including a successful partnership with Monarch and a new reseller agreement with 3DR Labs for AI imaging solutions, signify potential for accelerated market adoption and broader commercialization. Additionally, the reaffirmation of its 2026 revenue guidance of $35 million indicates strong confidence in future growth driven by increased unit placements and diverse revenue channels.

Bears say

Nano X Imaging Ltd has reported a decline in cash reserves, decreasing from $83.2 million to $55.5 million, primarily due to a significant operating cash burn of $30.4 million and limited at-the-market (ATM) usage. The company's revenue growth expectations have been consistently lowered over the past year, indicating challenges in generating anticipated income. Additionally, the GAAP gross loss remains high at $2.9 million, alongside a stable net loss of $13.7 million, highlighting ongoing investment burdens and a lack of profitability in its operational segments.

Nano-X Imaging (NNOX) has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Buy based on their latest research and market trends.

According to 2 analysts, Nano-X Imaging (NNOX) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.